Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1715 results
Cellectar introduces PDC platform for targeted delivery of chemotherapeutics
By PBR Staff Writer
Cellectar Biosciences (CLRB) has introduced its phospholipid ether-drug conjugate (PDC) platform for expanding the use of its small-molecule cancer targeting and delivery technology for targeted delivery of chemotherapeutics.
Automation > IT & Software > News
Seres secures FDA orphan drug status for SER-109 to prevent recurrent CDI in adults
By PBR Staff Writer
Seres Therapeutics has received orphan drug designation from the US Food and Drug Administration (FDA) for its oral therapeutic, SER-109, being evaluated in a Phase II clinical trial for the prevention of recurrent Clostridium difficile infection (CDI) in adults.
Automation > IT & Software > News
EnGeneIC begins Phase I tailored-EDV clinical trial in solid tumors
By PBR Staff Writer
Australian biopharmaceutical firm EnGeneIC has dosed the first patient in its Phase I Tailored-EDV clinical trial, which is being conducted at the Northern Cancer Institute in Sydney.
Automation > IT & Software > News
Insys's NDA for Dronabinol oral solution accepted for filing by US FDA
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for filing Insys Therapeutics' new drug application (NDA) for its Dronabinol Oral Solution, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a synthetic version of tetrahydrocannabinol (THC).
Automation > IT & Software > News
Genmab ties up with Novo Nordisk for DuoBody technology
By PBR Staff Writer
Genmab has inked a pact to allow Novo Nordisk to use commercial licenses for DuoBody technology platform to create and develop bispecific antibody candidates for two therapeutic programs.
Automation > IT & Software > News
Boehringer to use Circuit optogenetics technology to develop new obesity drugs
By PBR Staff Writer
Boehringer Ingelheim has entered into a second collaboration with US-based Circuit Therapeutics to use its optogenetics technology platform for the discovery and development of new medicines to treat obesity and associated diseases.
Automation > IT & Software > News
Poseida to use Janssen Centyrin technology to develop CAR therapies
Poseida Therapeutics (Poseida), a private biotechnology company spun out of Transposagen Biopharmaceuticals (Transposagen), and headquartered in San Diego, CA, announced they have entered into a worldwide License Agreement with Janssen Biotech (Janssen) to research, develop, manufacture and commercialize licensed products using Janssen Centyrin technology.
Automation > IT & Software > News
iCardiac acquires nSpire Health's clinical trials division
iCardiac Technologies, a global provider of cardiac safety assessment services to the pharmaceutical industry, announced today that it has added leading respiratory and ePRO services to its suite of offerings through the acquisition of the clinical trials division of nSpire Health.
Automation > IT & Software > News
AstraZeneca enters $510m Heptares deal to develop new immuno-oncology treatments
By PBR Staff Writer
AstraZeneca and Sosei Group's subsidiary Heptares Therapeutics have entered into an agreement to develop new immuno-oncology treatments.
Automation > IT & Software > News
Aprecia's first 3D printed drug product Spritam gets FDA approval to treat epilepsy
By PBR Staff Writer
Aprecia Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for Spritam levetiracetam for oral use as a prescription adjunctive therapy to treat partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy.
Automation > IT & Software > News
BMG Pharma signs distribution agreement with Sayre Therapeutics
BMG Pharma is pleased to announce the signature of a Distribution Agreement with Sayre Therapeutics, Bangalore, India, for its cancer supportive products under the brand name GelX and for its liposomal iron based food supplement IronOne.
Automation > IT & Software > News
Pediatric cancer treatment based on Nanosmart platform obtains FDA's orphan drug status
By PBR Staff Writer
US-based NanoSmart Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for a second drug product that uses the company's drug delivery platform.
Automation > IT & Software > News
Ligand licenses Captisol to Sanofi for development of MET kinase inhibitor
By PBR Staff Writer
Ligand Pharmaceuticals (LGND) has licensed chemically modified cyclodextrin Captisol to Sanofi for use in the development and commercialization of SAR-125844, a potent MET kinase inhibitor.
Automation > IT & Software > News
EyeGate gets USPTO notice of allowance for proprietary dexamethasone phosphate formulation
Eyegate Pharmaceuticals (EYEG), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, announced that it has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its lead product candidate, EGP-437.
Automation > IT & Software > News
Pulmatrix issued patents covering iSPERSE technology to treat patients with inhaled dry powders
Pulmatrix (PULM) has been granted two patents from the US Patent and Trademark Office (U.S. Patent # 8,992,983 and US patent # 9,061,352), which cover the composition of matter for the company's underlying iSPERSE (inhaled Small Particles Easily Respirable and Emitted) inhaled dry powder technology as well as methods for treating a subject using respirable dry powders.
Automation > IT & Software > News
91-105 of 1715 results